Value of Liquid-Based Cytology Test Combined with HR-HPV Testing in CINⅢafter LLETZ During Follow-Up

张艳萍,吴瑞芳,刘志红,汤惠茹,王纯,周艳秋
DOI: https://doi.org/10.3969/j.issn.1000-8179.2013.11.010
2013-01-01
Chinese Journal of Clinical Oncology
Abstract:Objective:This study aimed to evaluate the value of liquid-based cytology test(LCT)combined with high-risk human papillomavirus(HR-HPV)testing in cervical intraepithelial neoplasia gradeⅢ(CINⅢ)after large-loop excision of the transformation zone(LLETZ)during follow-up. Methods:Clinical analysis was used to investigate 567 patients diagnosed with CINⅢand treated with LLETZ from May 2003 to May 2009 at Peking University Shenzhen Hospital. The patients were enrolled in a follow-up program set at 3 months, 6 months, and every 6 to 12 months. LCT and HR-HPV testing were used as monitoring indicators to evaluate HR-HPV testing after LLETZ during follow-up. Results:1)The residual lesion predicting capacity of postoperative LCT obtained the following:sensitivity, 60%:specificity, 88.15%:positive predictive value, 8.30%;and negative predictive value, 99.19%. The residual lesion predicting capacity of HPV testing obtained the following:sensitivity, 100%:specificity, 85.64%:positive predictive value, 11.11%;and negative predictive value, 100%. The recurrent lesion predicting capacity of postoperative LCT obtained the following:sensitivity, 63.64%;specificity, 92.27%;positive predictive value, 14.00%;and negative predictive value, 99.23%. The recurrent lesion predicting capacity of HPV testing obtained the following:sensitivity, 72.73%;specificity 85.97%;positive predictive value 9.30%;and negative predictive value, 99.38%. 2)The recurrent lesion rate was higher in postoperative persistent HPV infection patients than in non-postoperative persistent HPV infection patients , Ther were statistically significant differences between the persistent negative and non-testing preoperative group(P<0.05). The recurrence rate was higher in persistent HPV-positive and HPV-re-infected patients than in the negative conversion group, whereas no recurrent lesion was found in persistent HPV-negative patients. Conclusion:Results showed the importance of predicting residual and recurrent lesions by LCT and HR-HPV testing, which were also confirmed to be effective methods in follow up. Postoperative persistent HPV-positive status is associated with recurrence and requires consistent follow-up.
What problem does this paper attempt to address?